close

Strike action from Thursday 27 June to Tuesday 2 July 2024

Junior doctors at The Christie will strike from 7am on Thursday 27 June until 7am on Tuesday 2 July 2024.

We are proactively contacting patients with appointments that may be affected. If you have an appointment on any of these dates, please continue to come to The Christie and our other centres as planned, unless we contact you to tell you otherwise. Please do not call to check if your appointment is still going ahead.

Skip to Content

Magnetic resonance imaging

Magnetic Resonance (MR) Imaging is a highly complex non-invasive type of imaging. It uses strong magnetic fields and radiofrequency waves to create detailed images of a patient’s internal anatomy and physiology. Unlike many other types of imaging, there is no ionising radiation hazard for the patient. The strong magnetic fields and radiofrequency waves create unique, serious hazards for patients with certain medical implants and for certain medical equipment, which require careful management.

The MR physics service at Christie Medical Physics and Engineering (CMPE) comprises 8 clinical scientists and 4 MR physicists who divide their time between multiple departments within The Christie and across over 40 scanners in NHS Trusts in the North West of England via regional contracts.

The MR physics group regularly work on site in each MR department, which smoothly integrates the important role of MR physics into a wide range of clinical services across the region. Regular time spent on site at each Trust is crucial to provide such high level, integrated support.

The support provided involves working closely with senior radiographers, radiologists, oncologists and radiology service managers to ensure the efficient and safe running of each service. The MR physics group members at The Christie pride themselves on a friendly, inclusive and collaborative approach to delivering the very best service to MR departments and their patients.

In 2024, the CMPE MR physics group were shortlisted for the Chief Scientific Officer’s healthcare science service of the year at the advancing healthcare awards for the introduction of three new innovative services, where they were highly commended by the judging panel for bringing ‘innovation in the fast lane’ You can see all of the winners including The Christie’s commendation on the Advancing Healthcare Awards website.

The MR physics group supports a wide range of MR scanning activities at The Christie. The radiology department has 1 3T and 3 1.5T scanners and offers clinical imaging for patient diagnosis, routine follow up post-cancer treatment, and radiotherapy treatment planning.

The unique Elekta Unity MR-Linac, which combines a linear accelerator and MR scanner, enables a patient to have 1.5T MR imaging and adaptive radiotherapy treatment on the same machine, in the same appointment. The proton beam therapy centre at The Christie has a 1.5T MR scanner to assist proton beam therapy treatment planning.

In addition to our comprehensive routine clinical scientist support, the MR physics group provides additional support for the MR for radiotherapy (MR-RT) services at the trust via extensive system QA and service review. There is ongoing work to ensure MR imaging for external beam radiotherapy treatment planning meets the recommendations in the IPEM topical report. We provide support for MR-RT sequence and QA services both within the trust and externally across the region.

The MR physics group is actively involved in novel MR research, primarily through strong links to the Radiotherapy Related Research group at The University of Manchester. This research focuses on the development of MR techniques for guiding the delivery of radiotherapy and evaluating therapy response. The group has a strong track record with oxygen-enhanced (OE) MRI for RT, dynamic contrast-enhanced (DCE) MRI and diffusion MRI, on standard MR scanners and the MR-Linac. This research forms part of the Radiotherapy BioAdaption theme within the Cancer Research UK Manchester Centre, and the functional imaging adaptation programme within the Manchester Biomedical Research Centre.

The MR physics group provides support to many NHS trusts throughout the North West of England. Support is tailored to the individual needs of each department. This unique position allows best practice to be shared throughout the region, including high level support to individual NHS trusts during the development of new local services.

Key elements of our service include:

  • Ensuring MR department compliance with the Control of Electromagnetic Fields at Work (CEMFAW) Regulations 2016
  • Provision and regular update of all necessary MR Safety Framework documentation and implant policies
  • MRSE services from our team of expert MR clinical scientists (including IPEM certified, and MRSCTM certified MRSEs)
  • Support with documentation to obtain and retain Imaging Services Accreditation from UKAS
  • MR safety procedures for complex services such as the scanning of patients with unapproved cardiac implanted electronic devices, with off-label medical devices and MR scanning of patients under general anaesthetic
  • Expert input to ensure that imaging protocols are optimised for both acquisition time and image quality, including extensive experience of MR advanced acceleration technology (AAT) implementation
  • Specialist support with site planning and scanner specification when replacing, upgrading or installing additional MR equipment
  • Acceptance testing of any new equipment
  • Investigation of MR safety incidents
  • Ensuring the QA requirements of the NHSBSP Report 68 guidance are met for sites offering MR screening scans for women at higher risk of breast cancer

This is achieved through regular on-site, in-person visits to each department across the region. We also provide remote support via email, and video or phone calls for urgent queries. We regularly review our practice to develop and improve the service we offer to MR departments, and their patients, through audit and continuing professional development (CPD).

The MR physics group has played a major role in the NHS England Improvement (NHSEI) MRI advanced acceleration technology (AAT) rollout in the North West of England. We have supported many trusts in achieving significant gains in imaging capacity in MR. Our large MR physics group is ideally placed to lead and support projects such as this across the North West Imaging Networks.

The MR group has a strong tradition of delivering excellent MR safety and MR physics teaching. CMPE are the leading accredited training centre in the region for the training of new clinical scientists via the NHS Scientist Training Program (STP) and contribute to the development of clinical scientists on the Higher Specialist Scientific Training (HSST) national program via teaching and academic supervision. We have a lead role in delivering training to provide the MR physics workforce required across the North West Imaging Networks.

In addition to STP and HSST, our teaching, training and outreach activities include:

  • Postgraduate teaching at the Universities of Manchester, Liverpool and Cumbria for MR radiographers and healthcare scientists
  • Development and delivery of the Corsmed MR Radiographer upskilling course for the North West Imaging Academy
  • Teaching on the FRCR programme for radiologists
  • Regular, tailored MR safety and MR physics talks for MR radiographer colleagues across the region and nationally, in addition to the customer learning hub below
  • Online customer learning hub where we host a wide variety of training material for radiology staff across the region
  • Regular customer newsletter containing important MR safety and MR physics updates and educational material
  • Outreach and public engagement to highlight the work of medical physicists in healthcare

Across the MR group, we are involved with professional bodies and national activities including:

  • External advisor for IPEM Clinical Scientist Guided Training Scheme
  • Association of Clinical Scientists (ACS) assessor for route 2 training scheme
  • National working parties and task and finish groups, e.g. membership of IPEM MR for RT working party and STERIC, the IPEM Science, Technology and Engineering Research and Innovation Council
  • Co-chair of the IPEM Advanced Acceleration Technology Task and Finish Group and responsible for a valuable online resource for this technology (MR Advanced Acceleration Technology - IPEM)
  • North West Imaging Academy Governance Board membership
  • Contributing articles to trade magazines such as SCOPE and Radmag
  • IPEM MRSE Portfolio Assessor

These voluntary roles bring huge benefits for both group members and the customers we support and ensure the MR group are closely involved in developing the profession and informing national policy making.

Steve Jackson – consultant clinical scientist

Steve is a consultant clinical scientist and the group leader of the imaging with non-ionising section at The Christie. Steve completed the NHS Scientist Training Programme (STP) with the MR group in 2018, following a BSc (Hons) in maths and physics and an MSc in theoretical physics. He took over leading the group in 2024.

His current work involves leading the MR physics group through an ever-changing landscape and developing MR physics support services within the North West Imaging Networks. Steve has a strong track record teaching MR physics and MR safety, including significant input into the design of the ‘Clinical MRI’ CPD module at the University of Liverpool and the Corsmed MR simulator course in collaboration with the North West Imaging academy. In April 2022, he became an IPEM certified MR Safety Expert (MRSCTM).

Dr Judith Kilgallon – principal clinical scientist

Judith joined The Christie as a trainee clinical scientist having completed her degree in Physics from the University of Leeds and PhD in Experimental Nuclear Structure Physics from The University of Manchester. Judith leads the support of our trainee clinical scientists and is heavily involved with the group’s teaching activities. Her clinical work stretches across much of the group’s regional service.

Michael Dubec – principal clinical scientist

Michael joined the MR group in 2014 after completing a BSc (Hons) in Physics, an MSc in Medical Radiation Physics and an MSc in Clinical Science (Medical Physics) as part of the NHS Scientist Training Programme. In addition to his clinical duties, Michael is heavily involved with developing MR for radiotherapy planning, guidance and assessing treatment response and was co-author of the IPEM national guidance on MR for radiotherapy treatment planning. He is also currently undertaking a part-time PhD entitled ‘Optimising oxygen-enhanced MRI biomarkers of hypoxia for use in advanced radiotherapy’.

Dr James Harkin – principal clinical scientist

James started working at The Christie in summer 2022. James' interest in MR began during their undergraduate physics degree, after which they undertook a PhD in MRI, focussing on hyperpolarised respiratory MRI. Later, James moved to working in the NHS at University Hospitals Dorset, where they achieved HCPC registration through route 2, as well as IPEM MR Safety Expert Certification. James is also a member of the STERIC, IPEM's strategic council, which oversees scientific, academic, innovation and research activities.

Guy Drabble – principal clinical scientist

Guy originally joined The Christie back in 2014 on the medical physics STP, having completed a degree in physics with particle physics and cosmology. He completed his training in 2017, specialising in radiotherapy and gaining his MSc in Clinical Science (Medical Physics).

Guy briefly left The Christie in 2019 to work in the education sector. Working at The University of Manchester, he helped to run the academic section of the Higher Specialist Scientist Training (HSST) programme. Guy has used this experience to develop the Corsmed MR Simulator course in collaboration with the North West Imaging Academy.

Rachael Franklin – principal clinical scientist

Rachael joined the group in 2023 from Guy’s and St Thomas’ in South London where she completed the Scientist Training Program (STP) between 2019-2022. Whilst there, she also supported the fetal cardiac MRI service, led computing support to the team, and supported rotational STP training. Prior to her training in medical physics, she worked at Metaswitch, testing networking and automation software.

Rachael will be providing clinical support to a number of sites across the North West region.

Chris Moore – clinical scientist

Chris completed an undergraduate physics degree at The University of Manchester. After a brief time as a software engineer, he successfully applied for the Scientist Training Programme (STP) in medical physics. He completed the programme in September 2021 and has taken on a clinical role in the MR group.

Chris splits his time between regional physics support and providing research support to the Radiotherapy Related Research group, with research interests including image registration, quantitative MR imaging biomarkers and longitudinal quantitative quality assurance of DWI images.

Dr Damien McHugh – MR physicist

Damien joined the MR group in January 2021. He is currently working towards acquiring his HCPC registration, having completed a PhD at The University of Manchester. His research was mainly focused on diffusion-weighted imaging and his PhD thesis was entitled ’The effect of tumour microstructure on diffusion-weighted MRI measurements'.

Damien has a 50/50 split role within the group, dedicating half of his time to providing clinical MR support to our regional sites and utilising his strong academic background for the other half by supporting radiotherapy-related MR research at The Christie.

Asher Ezekiel – clinical scientist

Asher joined the MR group through the Scientist Training Program (STP) and completed his training in 2023. He has since taken on a clinical role providing physics support to sites across the North West and supporting the MR for radiotherapy services at The Christie and Salford. Before joining the STP, Asher completed his undergraduate degree in Physics at the University of Birmingham. He then moved to London to join a publishing company where he worked for a leading online science journal and completed an MSc in Astrophysics at Queen Mary, University of London.

Hanna Hanson – MR physicist

Hanna joined the group in July 2023 and is working towards HCPC registration through route 2. Prior to this she undertook a PhD in the University of Manchester Radiotherapy Related Research group. Her research focused on respiratory motion management on the MR-linac and she has recently submitted her thesis entitled ‘Methods for fast and accurate MR-guided lung radiotherapy’. Her role in the MR physics group is split between providing clinical MR support and conducting MR research at The Christie.

Dr Sam Curley – trainee clinical scientist

Sam started at The Christie in 2021. After completing the first year of his STP training, he elected to specialise in MRI and officially joined the MR group in late 2022. Prior to working at The Christie, Sam completed a PhD at The University of Warwick. This focused on studying low-dimensional magnetic materials under a variety of extreme conditions, such as low-temperatures and high pressure.

Having moved to Manchester, Sam is currently undertaking the final year of his STP training. His day-to-day efforts are geared towards growing his MR knowledge and learning the various ways in which the group delivers MR-related support to the region. This can range from implementing advanced MRI acceleration techniques to helping provide sites with bespoke MR safety guidance.

Peter Latimer – trainee clinical scientist

Peter joined the MR group through the medical physics STP and is in the specialist part of his training. In 2020, he received his MPhys (Hons) in Theoretical Physics at the University of Manchester and went on to complete a Professional Graduate Diploma in Education (PDGE) while working as a science teacher at a local secondary school.

The MR group is active in the MR research community. Across the group, we regularly author and contribute to scientific papers and present at national and international research meetings. 

Recent publications and selected conference involvement

2024

Publications

  • Lisa McDaid, Abigael Clough, Rebecca K Benson, Claire Nelder, John McMahon, Steven Jackson, Marianne Aznar, Ananya C Choudhury, Marcel van Herk, Cynthia L Eccles, Geometric distortion caused by metallic femoral head prosthesis in prostate cancer imaging on an MR Linac: in-vivo measurements of spatial deformation, British Journal of Radiology, Volume 97, Issue 1156, April 2024, Pages 757–762

Conference involvement (asterisk denotes speaker) 

  • Dubec MJ*, Berks M, McDaid L, Little RA, Gaffney J, Price J, Cheung S, Porta N, Matthews JC, Choudhury A, van Herk M, McPartlin A, Parker GJM, Buckley DL, O'Connor JPB. Translation of dynamic contrast enhanced MRI in head and neck cancer to the MR Linac. ESTRO 2024, 1300.
  • Ezekiel A*, Swinton M, Buckley DL, Choudhury A, Eccles CL, Hoskin P, Dubec M, McHugh D. Blood oxygenation level dependent (BOLD) MRI of the prostate on an MR Linac. ESTRO 2024, 1834.
  • McHugh DJ*, Greenwood-Wilson A, McDaid L, Eccles C, Thomson D, Buckley DL, Choudhury A, van Herk M, Dubec MJ. Developing geometrically robust diffusion-weighted MRI for head and neck imaging on an MR-Linac. ESTRO 2024, 2478.
  • Moore C, Swinton M, Vasquez Osorio E, McHugh D, Bristow R, van Herk M, Choudhury A, Buckley DL, Sachdeva A, Clarke N, Oates J, Dubec MJ. Feasibility of oxygen-enhanced MRI measurement in the whole prostate on an MR-Linac. ESTRO 2024, 2458.
  • Jackson S*, M Hutton. Implementation of advanced acceleration techniques. ISMRM 2024

2023

Publications

  • Dubec MJ, Buckley DL, Berks M, Clough A, Ganey J, Datta A, McHugh DJ, Porta N, Little RA, Cheung S, Hague C, Eccles CL, Hoskin PJ, Bristow RG, Matthews JC, van Herk M, Choudhury A, Parker GJM, McPartlin A, O'Connor JPB. First-in-human technique translation of oxygen-enhanced MRI to an MR linac system in patients with head and neck cancer. Radiother Oncol. 2023;183:109592.
  • Zhong J, Brown S, Serra M, Shuttleworth P, Bownes P, Thompson C, Reed, Reeves K, Dubec M, McHugh D, Eccles C, Chuter R, Tsang YM, Taylor J, West C, Buckley D, Scarsbrook A, Choudhury A, Hoskin P, Henry A. Reirradiation options for previously irradiated prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT). BMJ Open 2022;0:e068580.

Conference involvement (asterisk denotes speaker) 

  • Dubec MJ*, Gaffney J, Buckley DL, Berks M, Datta A, McHugh DJ, Little RA, Cheung S, Hague C, Matthews JC, Choudhury A, van Herk M, McPartlin A, Parker GJM, O'Connor JPB. Oxygen-Enhanced MRI Assessment of Radiotherapy-Induced Treatment Effects in Patients with Head and Neck Cancer. ISMRM 2023, 0894.
  • Datta A, McHugh DJ, Dubec MJ, Buckley DL, Little R, Berks M, Cheung S, West C, Choudhury A, Hoskin P, O'Connor JPB. Evaluating intra-voxel incoherent motion in the uterine cervix: healthy volunteer repeatability and therapy-induced changes in tumours, ISMRM 2023, 0732.
  • McHugh DJ, Datta A, Dubec MJ, Buckley DL, Little RA, Berks M, Cheung S, West C, Choudhury A, Hoskin P, O'Connor JPB. Evaluating radiotherapy response in uterine cervical tumours using intra-voxel incoherent motion MRI. ESTRO 2023, PO-2069.
  • Moore C, Clough A, Nelder C, Eccles C, Hoskin P, Chuter R, Zhong J, McHugh D, Choudhury A, Dubec M. Optimising the MRL Consortium Biomarkers Group Prostate DWI Sequence Image Quality & ADC Comparison. ESTRO 2023, PO-2075.
  • Jackson, S*. Rapid Multi-vendor AAT to increase imaging capacity. IPEM MRI Protocol Development: Clinical Standardisation and Optimisation 2023.
  • M Hutton*, Siemens MR Symposium. Invited speaker: Deep Resolve implementation
  • M Hutton*, UKIO (Liverpool). Invited speaker: Accelerating MRI for clinical benefit
  • M Hutton, IPEM T&F Group webinar on Advanced Acceleration technology – Philips, https://youtu.be/n6LBf_IqiKw?si=_dqtfX9jcvhXFlEs
  • S Jackson, IPEM T&F Group webinar on Advanced Acceleration technology – Overview, https://youtu.be/zXUmufUCr38?si=zfr_3FKkf5p7dif
  • J Kilgallon, S Jackson, M Hutton, IPEM MR Safety Update. Poster: Audit of MR Unlabelled & Off-Label Risk Assessments
  • S Jackson, J Harkin, M Hutton*, N Woodhouse, S Phenna, IPEM MR Safety Update. Oral presentation:, Effectively-MR Conditional cardiac implantable electronic devices
  • M Hutton, S Jackson, D McHugh, L Brindle, R Holden, R Mehan, B Soni, IPEM MR Safety Update. E-poster: Off-label scan of a NeuroControl FREEHAND® peripheral nerve neurostimulator in a tetraplegic patient
  • J Harkin, S Curley, S Jackson, S Phenna, M Hutton, IPEM MR Safety Update. Poster: Using 3D CT Reconstructions to Widen Access to MR for Patients with Aneurysm Clips
  • Ezekiel A, Drabble G, Jackson S, Hutton M, An audit of patient-specific MR safety queries for a large MR Safety Expert service, STEF, February 2023

2022

Publications

  • Andreas Wetscherek, Erik van der Bijl, Astrid L. H. van Lier, Joan Chick, Steven Jackson, Stephen Gibson, Vivian van Pelt, Signe W. Hasler and Rob H. N. Tijssen, Longitudinal Stability of MRI QA up to Two Years on Eight Clinical 1.5 T MR-Linacs. Front. Phys., 13 June 2022 Sec.Medical Physics and Imaging https://doi.org/10.3389/fphy.2022.891600
  • Rosie B Hales, Robert Chuter, Alan McWilliam, Amal Salah, Michael Dubec, Linnea Freear, Lisa McDaid, Marianne Aznar, Marcel van Herk, Andrew McPartlin, Cynthia L Eccles. The impact of gadolinium-based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac. Medical Physics, 2022 Jan;49(1):510-520. doi: https://doi.org/10.1002/mp.15325.
  • James Harkin, Cameron Ingham. Comparison of snr assessment techniques for routine multi-element rf coil qc testing. IPEM-Translation, 1 July 2022;2_100012. https://doi.org/10.1016/j.ipemt.2022.100012

Conference involvement (asterisk denotes speaker) 

  • M Dubec*, A Datta, A Clough, DL Buckley, RA Little, M Berks, S Cheung, C Eccles, D Higgins, JH Naish, JC Matthews, M van Herk, RG Bristow, GJ Parker, P Hoskin, A McPartlin, A Choudhury, JP O’Connor, ESTRO (Copenhagen). Presentation: First-in-human clinical translation of oxygen-enhanced MRI onto an MR Linac.
  • M Dubec*, A Datta, RA Little, A Clough, DL Buckley, C Hague, M Berks, S Cheung, A Salah, D Higgins, C Eccles, RG Bristow, JH Naish, JC Matthews, P Hoskin, M van Herk, , GJ Parker, A Choudhury, A McPartlin, JPB O’Connor, ISMRM (London). Presentation: First in-human technique translation of OE-MRI for hypoxia imaging onto an MR Linac system in patients with head and neck cancer.
  • M Dubec*, A Datta, RA Little, A Clough, DL Buckley, C Hague, M Berks, S Cheung, A Salah, D Higgins, C Eccles, RG Bristow, JH Naish, JC Matthews, P Hoskin, M van Herk, , GJ Parker, A Choudhury, A McPartlin, JPB O’Connor, Elekta MR Linac Consortium Meeting (Texas & virtual). Presentation: First in-human technique translation of OE-MRI for hypoxia imaging onto an MR Linac system in patients with head and neck cancer.
  • S Jackson*, UKIO (Liverpool). Implementing advanced acceleration technology (AAT) in clinical MR (BAMRR session).
  • S Jackson*, D McHugh, C Moore, G Drabble, D Buckley, IPEM MR in RT meeting (Manchester). Presentation: Evaluating an existing MR for RT service against IPEM guidance.
  • D McHugh*, UKIO (Liverpool). Invited speaker: MR functional imaging techniques - basic principles.
  • A Clough*, D McHugh*, M Dubec, L Barraclough, K Haslett, A Choudhury, C Eccles, Elekta MR-Linac Consortium meeting (Texas & virtual). E-poster: DW-MRI in the cervix: repeatability and on-treatment changes of the apparent diffusion coefficient.
  • D McHugh*, M Dubec, J Price, C Moore, D Buckley, JPB O'Connor, A McPartlin, ISMRM (London). E-poster: Identifying perfused tissue regions through IVIM and ADC model comparison: technical validation.
  • C Moore, D McHugh*, A Clough, J Stickley, R Chuter, A Choudhury, M Dubec ISMRM (London). Lightning presentation: Daily Measurement of Prostate ADC in Patients Undergoing SABR and Conventional Treatment for Prostate Cancer on an MR-Linac
  • C Moore, D McHugh, A Clough, J Stickley, R Chuter, A Choudhury, M Dubec, ESTRO (Copenhagen) E-poster: Daily Measurement of Prostate ADC in Patients Undergoing SABR and Conventional Treatment for Prostate Cancer on an MR-Linac.
  • C Moore*, D McHugh, A Clough, J Stickley, R Chuter, A Choudhury, M Dubec IPEM MR in RT (Manchester). Oral presentation: Daily prostate ADC in patients having SABR or conventional prostate radiotherapy on an MR-Linac
  • M Hutton*, BIR webinar: Accelerated MRI – Hype or Hope for Increased Patient Throughput. Invited speaker: Accelerated MR imaging: practical implementation

2021

Publications

  • Lewis D, McHugh DJ, Li K-L, Zhu X, McBain C, Lloyd SK, Jackson A, Pathmanaban ON, King AT, Coope DJ. Detection of early changes in the post-radiosurgery vestibular schwannoma microenvironment using multinuclear MRI. Scientific Reports 2021;1115712. https://doi.org/10.1038/s41598-021-95022-6
  • McDaid L, Hutton M, Cooper L, Hales RB, Parry C, Waters J, Rodgers JE, Doherty W, Eccles CL. Developing electronic learning to deliver MR safety training in a radiotherapy department. J Med Imaging Radiat Sci. 2021 Dec;52(4S):S24-S31. https://doi.org/10.1016/j.jmir.2021.05.012
  • McHugh DJ, Porta N, Little RA, Cheung S, Watson Y, Parker GJM, Jayson GC, O'Connor JPB. Image contrast, image pre-processing, and T1 mapping affect MRI radiomic feature repeatability in patients with colorectal cancer liver metastases. Cancers 2021;13:240. https://doi.org/10.3390/cancers13020240
  • Speight, R, Dubec, M, Eccles, CL, George, B, Henry, A, Herbert, T, Johnstone, RI, Liney, GP, McCallum, H & Schmidt, MA. 'IPEM topical report: Guidance on the use of MRI for external beam radiotherapy treatment planning', Physics in Medicine and Biology, 2021, vol. 66, no. 5, 055025. https://doi.org/10.1088/1361-6560/abdc30
  • Speight, R, Tyyger, M, Schmidt, MA, Liney, GP, Johnstone, R, Eccles, CL, Dubec, M, George, B, Henry, A, Herbert, T, Nyholm, T, Mahmood, F, Korhonen, J, Sims, R, Tijssen, RHN, Vanhoutte, F, Busoni, S, Lacornerie, T & McCallum, HM. 'IPEM Topical Report: an international IPEM survey of MRI use for external beam radiotherapy treatment planning', Physics in Medicine and Biology, 2021. vol. 66, no. 7, 075007. https://doi.org/10.1088/1361-6560/abe9f7
  • Dubec M, Brown S, Chuter R, Hales R, Whiteside L, Rodgers J et al. MRI and CBCT for lymph node identification and registration in patients with NSCLC undergoing radical radiotherapy. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2021 Jun 1;159:112-118. https://doi.org/10.1016/j.radonc.2021.03.015

Conference involvement (asterisk denotes speaker) 

  • M Dubec, Christie Radiotherapy Summer School (Manchester). Invited talk: Optimising MRI for Radiotherapy.
  • M Hutton, BAMRR Annual meeting 2021 (online). Invited speaker: Hydrocephalus shunts and MR.
  • S Jackson, IPEM MR Safety Update (online). Invited Speaker: Imaging Cochlear Implants Safely.
  • S Jackson*, C Moore, A Wetscherek, IPEM MR QA conference (online). Lightning Presentation: Annual Review of B0 Homogeneity QA on the Elekta Unity MR Linac.
  • C Moore*, S Jackson, M Dubec, IPEM MR QA conference (online). Monthly Quantitative Diffusion QA Using the HPD Diffusion Phantom on a MR-Linac.

2020

Publications

  • Meshal Alzahrani, David A Broadbent, Robert Chuter, Bashar Al-Qaisieh, Steven Jackson, Hutton Michael, Robert I Johnstone, Simon Shah, Andreas Wetscherek, H. Joan Chick, Jonathan J Wyatt, Hazel Mhairi McCallum, Richard Speight. Audit feasibility for geometric distortion in magnetic resonance imaging for radiotherapy, Physics and Imaging in Radiation Oncology, Volume 15, 2020, Pages 80-84, https://doi.org/10.1016/j.phro.2020.07.004
  • Bellhouse S, Brown SM, Dubec M, Taylor S, Hales R, Whiteside L et al. Introducing magnetic resonance imaging into the lung cancer radiotherapy workflow – An assessment of patient experience. Radiography. 2020 May 23. https://doi.org/10.1016/j.radi.2020.04.020
  • Shortall, J, Vasquez Osorio, E, Mackay, R, Song, YP, Kirkby, K, Cree, A, Dubec, M, Chuter, R, Mcwilliam, A, Price, G & Van Herk, M. 'Inter- and intra-fractional stability of rectal gas in pelvic cancer patients during MRIgRT', Medical Physics, 2020. https://doi.org/10.1002/mp.14586  

Conference involvement (asterisk denotes speaker)

  • S Jackson, H Hanson, D Cobben, K Banfill, A Salem, L McDaid, M van Herk, B Rowland, ISMRM (online). E-poster: Intrinsically Registered Fat Saturated and Unsaturated T2W Images Using a Keyhole Method

2019

Publications

  • Jackson S, Glitzner M, Tijssen RHN, Raaymakers BW. MRI B0homogeneity and geometric distortion with continuous linac gantry rotation on an Elekta Unity MR-linac. Phys Med Biol. 2019 Jun 10;64(12):12NT01. https://doi.org/10.1088/1361-6560/ab231a
  • Tijssen RHN, Philippens MEP, Paulson ES, Glitzner M, Chugh B, Wetscherek A, Dubec Met al. MRI commissioning of 1.5T MR-linac systems – a multi-institutional study. Radiotherapy and Oncology. 2019 Mar 1;132:114-120. Available from, DOI: https://doi.org/10.1016/j.radonc.2018.12.011
  • Richard Speight, Maria A Schmidt, Gary P Liney, Robert I Johnstone, Cynthia L Eccles, Michael Dubec, Ben George, Ann Henry and Hazel McCallum. IPEM Topical Report: A 2018 IPEM survey of MRI use for external beam radiotherapy treatment planning in the UK.  Med. Biol.64 (2019) 175021. DOI: https://doi.org/10.1088/1361-6560/ab2c7c 

Conference involvement (asterisk denotes speaker) 

  • S Jackson*, A Cree, R Chuter, A McWilliam, IPEM MR in RT meeting (Edinburgh). Presentation: Simulation of Automatic Contour Propagation using Previous Imaging on an MR-linac.
  • S Jackson*, M Glitzner, RHN Tijssen, BW Raaymakers, ESTRO (Milan) Presentation: Feasibility of MRI-guided VMAT: investigating image quality during gantry rotation on an MR-linac.
  • M Hutton, UKIO (Liverpool). Invited speaker: MR Linac.
  • M Dubec*, A Salem, Y Watson, R Little, C Faivre-Finn, J Matthews, M van Herk, JPB O’Connor, GJM Parker, ISMRM (Montreal). Presentation: Dynamic OE-MRI mapping of lung parenchymal radiotherapy effects in non-small cell lung cancer patients.

Last updated: June 2024

© 2024 The Christie NHS Foundation Trust